Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5273181
Max Phase: Preclinical
Molecular Formula: C20H14ClN5OS
Molecular Weight: 407.89
Associated Items:
ID: ALA5273181
Max Phase: Preclinical
Molecular Formula: C20H14ClN5OS
Molecular Weight: 407.89
Associated Items:
Canonical SMILES: O=C1CS/C(=N\c2cc(-c3c[nH]c4ccccc34)nn2-c2ccc(Cl)cc2)N1
Standard InChI: InChI=1S/C20H14ClN5OS/c21-12-5-7-13(8-6-12)26-18(23-20-24-19(27)11-28-20)9-17(25-26)15-10-22-16-4-2-1-3-14(15)16/h1-10,22H,11H2,(H,23,24,27)
Standard InChI Key: MEWSJFGNFMLAHD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 407.89 | Molecular Weight (Monoisotopic): 407.0608 | AlogP: 4.52 | #Rotatable Bonds: 3 |
Polar Surface Area: 75.07 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.57 | CX Basic pKa: 0.94 | CX LogP: 4.69 | CX LogD: 4.47 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.52 | Np Likeness Score: -1.17 |
1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N.. (2023) Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors., 14 (3): [PMID:36970141] [10.1039/d2md00442a] |
Source(1):